The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia.
- Teo, ZL; Sawyer, SD; James, PA; Mitchell, G; Trainer, AH; Lindeman, GJ; Shackleton, K; Cicciarelli, L; Southey, MC;
Publication Year 2013-12, Volume 12, Issue #4, Page 587-595
- Journal Title
- Familial Cancer
- Publication Type
- Journal Article
- The familial aggregation of breast cancer has been well-described with approximately 25 % of breast cancers attributable to inherited mutations in currently known breast cancer susceptibility genes. PALB2 c.3113G>A (p.Trp1038*) is a protein-truncating mutation which has been associated with high estimated risk of breast cancer in Australian women (91 %; 95 % CI = 44-100) to age 70 years. This study screened for PALB2 c.3113G>A in germline DNA representing 871 unrelated individuals from "high-risk" breast and/or ovarian cancer families evaluated in the setting of a Familial Cancer Centre in Australia. The PALB2 c.3113G>A mutation was identified in eight of 871 probands (0.92 %) from these families. Median age of diagnosis was 42 years. Five of these eight women had contra-lateral breast cancers. Available data suggests that PALB2 c.3113G>A is a rare mutation with estimated breast cancer risks similar in magnitude to that associated with BRCA2 mutations. Although the proportion of high-risk women carrying this PALB2 mutation is low, research efforts should continue in order to effect its translation into clinical genetic testing practice.
- PALB2 Hereditary breast cancer ; Familial cancer centre ; BRCA1 and BRCA2 mutation negative
- WEHI Research Division(s)
- Stem Cells And Cancer
- Publisher's Version
- NHMRC Grants
- Rights Notice
- © Springer, Part of Springer Science+Business Media
Creation Date: 2013-12-01 12:00:00Last Modified: 0001-01-01 12:00:00